Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market 2022 by Company, Regions, Type and Application, Forecast to 2028

The B-Cell Maturation Antigen (BCMA) Targeted Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our Researcher latest study, due to COVID-19 pandemic, the global B-Cell Maturation Antigen (BCMA) Targeted Therapies market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Liver Cancer accounting for % of the B-Cell Maturation Antigen (BCMA) Targeted Therapies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Bispecific Antibodies segment is altered to a % CAGR between 2022 and 2028.

Global key companies of B-Cell Maturation Antigen (BCMA) Targeted Therapies include Transposagen Biopharmaceuticals, Sutro Biopharma, Malin Corporation, Eureka Therapeutics, and firstVentury Equity, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation



B-Cell Maturation Antigen (BCMA) Targeted Therapies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Bispecific Antibodies

Antibody Drug Conjugates

Chimeric Antigen Receptor T-Cells

Market segment by Application, can be divided into

Liver Cancer

Respiratory Cancer

Brain Cancer

Others

Market segment by players, this report covers

Transposagen Biopharmaceuticals

Sutro Biopharma

Malin Corporation

Eureka Therapeutics

firstVentury Equity

Five Prime Therapeutics

Credit Suisse Securities

Dana-Farber Cancer Institute

Deerfield Partners

Onyx Pharmaceuticals

Juno Therapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe B-Cell Maturation Antigen (BCMA) Targeted Therapies product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of B-Cell Maturation Antigen (BCMA) Targeted Therapies, with revenue, gross margin and global market share of B-Cell Maturation Antigen (BCMA) Targeted Therapies from 2019 to 2022.

Chapter 3, the B-Cell Maturation Antigen (BCMA) Targeted Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and B-Cell Maturation Antigen (BCMA) Targeted Therapies market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe B-Cell Maturation Antigen (BCMA) Targeted Therapies research findings and conclusion, appendix and data source.


Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports